AFGIX Fees and Costs — Alger Global Equity Fund, Class I

Data updated: 2026-09-25

The net expense ratio is 1.20%: a 0.80% management fee, a 0.25% 12b-1 fee plus 1.18% other expenses, less a 1.03% fee waiver. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $30K in broker commissions, 0.1419% of average net assets, and portfolio turnover was 87%.

AFGIX Fees and Expenses

Annual operating expenses and sales charges of AFGIX. Prospectus, as of October 31, 2025.

Annual operating expenses
Management fee0.80%
12b-1 fee0.25%
Other expenses1.18%
Gross expense ratio2.23%
Fee waiver−1.03%
Net expense ratio1.20%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

AFGIX Costs Over Time

On $10,000 invested in AFGIX, assuming 5% a year before costs, total costs come to $834 over 5 years, cutting the return by 1.41% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 1.20%)$126$392$677
Trading costs (broker commissions)$15$46$80
Lost growth on money paid in costs$0$22$77
Total costs$141$460$834
Value after costs$10,359$11,116$11,929
Impact on return, per year1.41%1.41%1.41%

AFGIX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): 0.1419%
  • Total broker commissions: $30K
  • Bought from dealers (principal trades, not a cost): $1
  • Portfolio turnover (prospectus): 87%
  • Securities lending: none during the year

AFGIX Agency Brokers

Commissions paid.

BrokerAmountShare
TOURMALINE PARTNERS, LLC$19K63.56%
CLSA LIMITED$10K33.79%
Jefferies & Company Inc$4401.45%
STIFEL, NICOLAUS & CO INC$2790.92%
PIPER SANDLER & CO.$860.28%
RBC DOMINION SECURITIES INC$20.01%

AFGIX Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
Prosetta Biosciences, Inc.$1100.00%

Alger Global Equity Fund Share Classes

Net expense ratio and maximum front-end load of each share class, cheapest first.

TickerClassNet expense ratioFront load
AFGZXClass Z0.99%—
AFGIXClass I1.20%—
CHUSXClass A1.20%5.25%
CHUCXClass C2.25%none

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.